Search

Your search keyword '"Rossi, Camillo"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Rossi, Camillo" Remove constraint Author: "Rossi, Camillo"
42 results on '"Rossi, Camillo"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals

3. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C

4. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

5. The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection

6. Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals.

9. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

10. Immune Responses to SARS-CoV-2 Infection and Vaccine in a Big Italian COVID-19 Hospital: An 18-Month Follow-Up

11. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

13. Immune Responses to SARS-CoV-2 Infection and Vaccine in a Big Italian COVID-19 Hospital: An 18-Month Follow-Up.

14. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

15. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

16. 126. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination

18. The impact of COVID-19 pandemic on AMI and stroke mortality in Lombardy: Evidence from the epicenter of the pandemic

22. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

25. An immune-based biomarker signature is associated with mortality in COVID-19 patients

26. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels

28. Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C.

29. Computer Vision Based Systems for Human Pupillary Behavior Evaluation: A Systematic Review of the Literature

30. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

31. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

32. Computer Vision Based Systems for Human Pupillary Behavior Evaluation: A Systematic Review of the Literature

36. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

37. Neoadjuvant model in cancer treatment: From clinical opportunity to health-care utility

38. The Experience of Setting up a Vascular Access Unit in a South European Large Hospital: The Step-by-Step Description of the First Year of Activity.

39. Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.

40. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

41. Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population Levels.

42. Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care Utility.

Catalog

Books, media, physical & digital resources